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Herpes Zoster Brachial Plexopathy: Direct Steroid Injection
ABSTRACT
which started 2 weeks after HZ skin eruption affecting to 
the left C4 and C6 dermatomes. In the patient’s history, the 
pain started with skin lesions and resolved at the end of the 
second weeks with oral acyclovir therapy. The patient did 
not define any pain at the admittance and he had no signs 
of cranial nerve or meningeal involvement. The skin lesions 
of HZ were extinguished and widely settled to periarticular 
region of the left shoulder, lateral surface of the left proximal 
arm and the left upper back. Motor strength examination of 
the left upper extremity revealed that motor power was 2/5 on 
shoulder abduction, external rotation and elbow flexion, 3/5 
on elbow extension and 4/5 on wrist and fingers. There were 
no pathological findings except for mild hypoesthesia at the 
periarticular area of left shoulder.
Patient’s routine biochemical tests were within normal limits. 
Brain, diffusion-weighted brain and cervical magnetic reso-
nance imaging (MRI) studies were normal at this time. Electro-
diagnostic studies (EDS) revealed a brachial plexopathy af-
fecting the upper, middle and lower trunks, but dominantly the 
upper trunk. The median, radial and ulnar nerves had slow 
conductivity whereas upper extremity muscles showed inten-
sive degenerative properties in EDS. Moreover, brachial plex-
us MRI was performed and contrast media enhancement was 
observed at the left brachial plexus (Figures 1, 2). 
█    INTRODUCTION
Herpes zoster (HZ) is a viral disease, caused by an exclusively human alpha herpes virus and is characterized by segmental painful skin rash and 
sensory symptoms. The most common complication of HZ 
is post-herpetic neuralgia (PHN), a syndrome characterized 
by neuropathic pain and allodynia in the affected region, 
persisting for months or even years after the rash has healed. 
However, motor involvement is rare, and brachial plexus 
neuritis is also very rare (2,3,6,7,10,11).
The main components of therapy of motor paresis or neuritis 
due to HZ are antiviral agents, pain therapy, and physiothera-
py. Some studies have showed that the use of corticosteroids 
in combination with antiviral agents reduces pain and acceler-
ates the healing process (8,9,11,14). We present a case with 
motor involvement of shoulder due to HZ and its treatment 
with brachial plexus injection by interscalene approach with 
local anesthetic with low concentration and triamcinolone.
█    CASE REPORT
A previously healthy 69-year-old male patient was referred to 
our clinic with the history of progressive left arm weakness 
Herpes zoster (shingles) is a viral disease, characterized by painful skin eruptions and neuropathic sensory symptoms. Motor 
involvement and brachial plexus involvement in herpes zoster are rare conditions. Together with antiviral medication and pain 
therapy, palliative and supportive modalities take an important role in the treatment of herpes zoster. It is well documented in 
previous reports that oral or intravenous steroid administrations may be additive in management. In this case report, positive effects 
of direct steroid injection onto the brachial plexus via ultrasonography guidance in a patient with motor weakness due to herpes 
zoster involvement of brachial plexus is presented.       
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For treatment, steroid was directly injected to the brachial 
plexus via interscalene approach under the guidance of 
ultrasonography (Figures 3, 4) with 40 mg triamcinolone and 
15 mg bupivacaine in total of 15 mL volume, and physical 
therapy for 4 weeks was recommended. Only one week 
after injection, the patients’ motor power was regained and 
weakness resolved within two months.
█    DISCUSSION
Herpes Zoster, better known as “shingles”, is the reactivation 
of dormant varicella zoster virus in the dorsal root ganglia 
and is characterized by segmental rash, pain and sensory 
symptoms. The incidence and severity of HZ increase with 
age, immune system incompetency and stress (1,3,7,10,11). 
Epidemiological studies have revealed motor involvement 
in 1-5% of patients with HZ (4,5,7). Brachial plexopathy is a 
very rare condition with an annual incidence of 1.64 cases 
per 100.000 persons (2). The associated motor neuropathy 
was probably due to an intense inflammatory demyelinating 
process and post-infectious immune-mediated motor root 
damage (7,10). Fabian et al. reported in their post-mortem 
histopathological evaluation of herpes zoster neuritis that 
extensive lymphocytic infiltration and myelin breakdown 
occur in affected site (4).
Clinically, PHN is characterized by ongoing burning, tingling, 
shooting and mechanical allodynia. These symptoms usually 
spread to one or two dermatomes. Motor involvement is not 
common, and motor symptoms may occur 1 to 3 weeks before 
or after dermatological findings (7,13). However, spreading 
of weakness or electrodiagnostic findings may not be in 
concordance with the involved dermatomes (1). Alshekhlee et 
al. comment in their report that, motor involvement ratio in HZ 
is higher than what is clinically detected. The low incidence of 
motor involvement of HZ is linked to difficult diagnosis of this 
pathological condition due to pain or subclinical conditions 
(1,3). In this patient, dermatologic findings began to regress 
at the onset of the weakness and the motor deficit started 
to become predominant and the quality of his life gradually 
decreased.
Figure 1: Brachial plexus MRI, contrast media enhancement was 
shown at left brachial plexus.
Figure 2: Brachial plexus MRI, contrast media enhancement was 
shown at left brachial plexus.
Figure 3: Demonstration of brachial plexus injection technique 
(Ultrasound guided interscalene approach).
Figure 4: Ultrasound image of the brachial plexus in the intersca-
lene groove (nerve roots marked by arrows). 
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Since we were not able to observe the initial spread of the 
lesions, it was not possible to make a true comparison 
of motor and dermatological involvement. However, EDS 
revealed a brachial plexopathy affecting all, but dominantly 
the upper trunk of the brachial plexus.
Treatment of PHN is difficult, and a variety of treatments are 
offered without consensus about their effectiveness. Antiviral 
agents, corticosteroids and other pain management modalities 
are used (8,9,11). Moreover, some interventional treatment 
modalities have also been reported including sympathetic 
blocks, epidural steroids, pulsed radiofrequency treatment or 
classic radiofrequency ablations (11,12). But, there has been 
no report on an effective treatment for promoting functional 
recovery from zoster paresis. Physical, occupational or 
psychotherapy methods have been reported in some case 
reports or case series. In our patient, oral antiviral therapy 
started at the beginning of the eruptions and pain, after this 
therapy pain and skin lesions were healed. Two weeks after 
the initiation of the skin lesions the patient was admitted to 
the hospital with progressive left arm weakness, there was no 
complaint about pain this time. First examination and cervical 
MRI of the patient showed no possible pathology but EDS 
revealed a brachial plexopathy. Similar to the case of Ayoub 
et al. (2), brachial plexus MRI performed with these results 
showed inflammation of the brachial plexus.
Steroids were directly administered onto the brachial plexus 
for the treatment of inflammation. For this purpose, we 
used an ultrasound-guided anesthetic technique known as 
“interscalene blockade” which is used for brachial plexus 
block. The patient’s weakness in the left arm almost completely 
resolved within 2 months. To the best of our knowledge, this 
is the first report of direct steroid injection to brachial plexus 
for HZ paresis. In our patient, progression of motor weakness 
disappeared in the first week with almost complete recovery 
at the end of second month. It has been previously reported 
that motor weakness could be resolved over a period of a 
few years (10). We attributed this rapid effect this expeditious 
effect of steroids to direct application in the inflammatory 
field whereby the inflammation in the affected site resolved 
immediately and functions rapidly returned. 
█    CONClUSION
Brachial plexus neuritis and motor paresis due to herpes 
zoster is a very rare condition, but it can limit daily life and can 
be disturbing for the patients. Since acute motor weakness 
may be related to many different reasons, the necessary 
radiological or electrodiagnostic tests should be performed. 
Additionally, if zoster pain or eruptions are included in the former 
history, motor involvement of HZ should be remembered. In 
such cases, direct steroid injection to the brachial plexus via 
different techniques should be kept in mind as an alternative 
treatment modality.
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